Delivery Order SPE2DB20D1100-SPE2DB24FC9S3

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DX15D1104|SPE2DX24F3HQ6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,120.36 firm fixed-price delivery order contract is for the supply of testosterone cypionate 200 mg/mL medication. The contract has an ultimate completion date of December 12, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award SPE2DB20D1109|SPE2DB25FN50W was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of testosterone cypionate 200 mg/mL. The $2,132.72 firm fixed-price delivery order contract has a completion date of February 7, 2025. This award is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
This federal contract award, with ID SPE2DB20D1109|SPE2DB24FN48X, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order valued at $1,951.26 and has a firm fixed price pricing type. The contract is for the supply of 'TESTOSTERONE CYP 200 MG/MLML', a pharmaceutical product, with a period of performance through January 25, 2024. The contract was awarded on January 24, 2024 and does not have a set-aside designation,...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ90K, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which has a ceiling value of $1,888.00, is for the delivery of testosterone cypionate 200 mg/mL, a pharmaceutical product. The contract is a Delivery Order under a Firm Fixed Price pricing type, with an ultimate completion date of January 6, 2025. This award is not...
This federal contract award, with the ID SPE2DB20D3104|SPE2DB24FV8Y4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $1,731.69 firm fixed-price delivery order is for the supply of 200 mg/mL testosterone cypionate, a medical commodity. This award is not designated as a set-aside contract. The contract has an ultimate completion date of August 23, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a...
This federal contract award with ID SPE2DB20D1100|SPE2DB24FD3Y4 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of testosterone cypionate 200 mg/mL. The $1,060.10 firm fixed price delivery order does not have a set-aside designation and has an ultimate completion date of August 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as well as several other Indefinite Delivery Contracts (IDCs) with the DLA...
The federal contract award ID SPE2DB20D2014|SPE2DB24FC59B is for the delivery of testosterone cypionate 200 mg/ml medication. The $1,952.61 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. This delivery order contract has a completion date of July 29, 2024 and is not designated as a set-aside contract. Amerisourcebergen has extensive experience supplying a wide range of...
This federal contract award, identified as SPE2DB20D1109|SPE2DB25FN19Y, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,746.02, is a delivery order for the supply of Testosterone CYP 200 mg/ml and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $1,934.70 firm fixed price delivery order is for 2,000 mg/10 ml testosterone cypionate in 10 ml vials. The contract has an ultimate completion date of June 24, 2025 and is not a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,034.80 firm fixed-price delivery order (SPE2DB20D1110|SPE2DB25FJ72K) is for the supply of "TESTOSTERONE CYP 200 MG/MLML" medical products, with a period of performance through October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC9S3
    Delivery Order

This federal contract award, with an ID of SPE2DB20D1100|SPE2DB24FC9S3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor. The contract, valued at $1,868.43, is a Delivery Order for the supply of Testosterone Cyp 200 mg/ml. This award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distributor, will provide the requested medication to support the DLA's medical supply requirements. The contract has a completion date of July 29, 2024.

Generated 10/25/24, 9:38 AM